UPC - Universe Pharmaceuticals INC
IEX Last Trade
0.688
0.051 7.340%
Share volume: 11,717
Last Updated: Thu 26 Dec 2024 08:24:11 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$0.64
0.05
7.92%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
0.57%
1 Month
-64.98%
3 Months
162.99%
6 Months
-73.48%
1 Year
-60.39%
2 Year
-93.44%
Key data
Stock price
$0.69
DAY RANGE
$0.61 - $0.66
52 WEEK RANGE
$0.16 - $4.93
52 WEEK CHANGE
-$68.31
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Gang Lai
Region: US
Website: www.dzrzy.com/
Employees: 220
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: www.dzrzy.com/
Employees: 220
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Universe Pharmaceuticals INC engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, and dietary supplements.
Recent news